SH2 domains as a target class in cancer and inflammation
New SH2 domain binding assays developed by Eurofins Discovery have been launched to support drug discovery initiatives in the protein-protein interaction space and in targeted protein degradation. We present small molecule case study data for important targets within this target class including STAT Transcription factors and Kinases.
Vitamin A and its role in psychiatric and other disorders
By Dr Murray Cairns (University of Newcastle), Ellen Capon (Drug…
Streamlining the path from lab to market with 3D bioprinting
By Dr Vidmantas Šakalys (Vital3D), Ellen Capon (Drug Target Review)
Women in STEM with Dr Petra Dieterich
By Dr Petra Dieterich (Abenza), Taylor Mixides (Drug Target Review)
Women in Stem with Katherine Tran
By Katherine Tran (SCIEX), Taylor Mixides (Drug Target Review)
Beyond the lab: artificial intelligence
Amidst the transformative era of artificial intelligence in drug discovery, this report focuses on recent advancements, notably the development of highly accurate drug target models, and how AI is revolutionising precision and effectiveness in identifying drug targets.
Vitamin A and its role in psychiatric and other disorders
By Dr Murray Cairns (University of Newcastle), Ellen Capon (Drug…
Streamlining the path from lab to market with 3D bioprinting
By Dr Vidmantas Šakalys (Vital3D), Ellen Capon (Drug Target Review)
Women in STEM with Dr Petra Dieterich
By Dr Petra Dieterich (Abenza), Taylor Mixides (Drug Target Review)
Women in Stem with Katherine Tran
By Katherine Tran (SCIEX), Taylor Mixides (Drug Target Review)